Pacer Data & Infra Real Estate ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Pacer Data & Infra Real Estate ETF trades at $28.9 (market cap $296.73M), while State Street SPDR S&P Biotech ETF trades at $149.89 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 34.1× Pacer Data & Infra Real Estate ETF's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Pacer Data & Infra Real Estate ETF for 10 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| SRVR | XBI | |
|---|---|---|
Market Cap | $296.73M | $10.11B |
Volume | 243,654 | 12,903,266 |
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $35.74 | $169.55 |
52-Week Low | $28.17 | $104.99 |
Typical Hold Time | 10 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $150.23, down 0.44% on the day, with a bearish technical signal driven by moving averages and oscillators. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than broader healthcare funds.
The outlook is mixed: strong sector tailwinds from innovation and consolidation support growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst sentiment is neutral with 100% hold ratings, suggesting cautious optimism amid technical bearishness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →